Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012

Leukemia and Lymphoma

Volumn 55, Issue 1, 2014, Pages 31-37

  Meignan, Michel ^a   Barrington, Sally ^b   Itti, Emmanuel ^a   Gallamini, Andrea ^c   Haioun, Corinne ^a   Polliack, Aaron ^d  

^a HENRI MONDOR HOSPITAL   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c S CROCE E CARLE HOSPITAL   (Italy)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Consensus; Lymphoma; PET

Indexed keywords

B LYMPHOCYTE; CANCER STAGING; CONTRAST ENHANCEMENT; ECONOMIC ASPECT; FOLLICULAR LYMPHOMA; FRANCE; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MEDICAL EXPERT; NONHODGKIN LYMPHOMA; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIMARY MEDIASTINAL LARGE CELL LYMPHOMA; PRIORITY JOURNAL; RADIOLOGY; REVIEW; T CELL LYMPHOMA; TUMOR VOLUME; VALIDATION STUDY; WORKSHOP;

HUMANS; LYMPHOMA; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84891350935     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.802784     Document Type: Review

References (14)

1. El-Galaly TC, D'Amore F, Mylam KJ, et al. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. J. Clin Oncol 2012; 30: 4508-4514.
2. Moulin-Romsee G, Hindie E, Cuenca X, et al. (18) F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J. Nucl Med Mol Imaging 2010; 37: 1095-1105.
3. Meignan M, Gallamini A, Haioun C, et al. Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010. Leuk Lymphoma 2010; 51: 2171-2180.
4. Cerci JJ, Trindade E, Pracchia LF, et al. Cost effectiveness of positron emission tomography in patients with Hodgkin's lymphoma in unconfi rmed complete remission or partial remission after first-line therapy. J. Clin Oncol 2010; 28: 1415-1421.
5. Trotman J, Fournier M, Lamy T, et al. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: Analysis of PET-CT in a subset of PRIMA trial participants. J. Clin Oncol 2011; 29: 3194-3200.
6. Luminari S, Versari A, Quaresima M, et al. Role of FDG-PET as prognostic indicator in patients with follicular lymphoma (FL) after immunochemotherapy induction. A retrospective study from the Fondazione Italiana Linfomi. Blood 2011; 118(Suppl. 1): Abstract 2636.
7. Dupuis J, Berriolo-Riedinger A, Julian A, et al. Impact of [(18) F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-Tumor burden follicular lymphoma treated with immunochemotherapy: A prospective study from the Groupe D'Etudes des Lymphomes de l ' Adulte and GOELAMS. J. Clin Oncol 2012; 30: 4317-4322.
8. Luminari S, Quaresima M, Versari A et al. The use of FDG-PET in the initial staging of patients with follicular lymphoma (FL). A retrospective study from the Fondazione Italiana Linfomi. Blood 2011; 118(Suppl. 1): Abstract 2651.
9. Bodet-Milin C, Touzeau C, Leux C, et al. Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: A retrospective study from the GOELAMS group. Eur J. Nucl Med Mol Imaging 2010; 37: 1633-1642.
10. Feeney J, Horwitz S, Gonen M, et al. Characterization of T-cell lymphomas by FDG PET/CT. AJR Am J. Roentgenol 2010; 195: 333-340.
11. Sasanelli M, Itti E, Biggi A, et al. Prognostic value of pretherapy metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in patients with diffuse large B-cell lymphoma (DLBCL). J. Nucl Med 2012; 53(Suppl. 1): Abstract 560.
12. Casasnovas RO, Sasanelli M, Berriolo-Riedinger A, et al. Baseline metabolic tumor volume is predictive of patient outcome in diffuse large B cell lymphoma. Blood 2012; 120(Suppl. 1): Abstract 1598.
13. Biggi A, Gallamini A, Chauvie S, et al. International validation study for interim PET in ABVD-Treated, advanced-stage Hodgkin lymphoma: Interpretation criteria and concordance rate among reviewers. J. Nucl Med 2013 Mar 20. [Epub ahead of print]
14. Tubiana M, Feinendegen LE, Yang C, et al. The linear no-Threshold relationship is inconsistent with radiation biologic and experimental data. Radiology 2009; 251: 13-22.